News stories about Dolby Laboratories (NYSE:DLB) have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dolby Laboratories earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news articles about the electronics maker an impact score of 46.0478402748916 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
DLB has been the topic of a number of analyst reports. B. Riley restated a “buy” rating and issued a $65.50 price objective on shares of Dolby Laboratories in a research report on Thursday, October 26th. Zacks Investment Research cut shares of Dolby Laboratories from a “hold” rating to a “sell” rating in a research report on Thursday, January 18th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Dolby Laboratories from $63.00 to $70.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. Dolby Laboratories has a consensus rating of “Hold” and a consensus price target of $62.00.
Shares of Dolby Laboratories (NYSE:DLB) traded down $0.46 on Thursday, hitting $61.86. 275,718 shares of the stock were exchanged, compared to its average volume of 437,635. The company has a market cap of $6,577.92, a price-to-earnings ratio of 98.19, a price-to-earnings-growth ratio of 5.35 and a beta of 0.78. Dolby Laboratories has a 52-week low of $48.00 and a 52-week high of $74.29.
The business also recently announced a quarterly dividend, which was paid on Wednesday, February 14th. Stockholders of record on Monday, February 5th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date was Friday, February 2nd. Dolby Laboratories’s payout ratio is 101.59%.
In other news, SVP Bob Borchers sold 148,361 shares of Dolby Laboratories stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $62.15, for a total transaction of $9,220,636.15. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Kevin J. Yeaman sold 100,000 shares of Dolby Laboratories stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $62.33, for a total transaction of $6,233,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 649,085 shares of company stock worth $40,507,528 in the last ninety days. Insiders own 43.80% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Dolby Laboratories (DLB) Getting Somewhat Positive News Coverage, Study Finds” was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.com-unik.info/2018/02/22/dolby-laboratories-dlb-getting-somewhat-positive-news-coverage-study-finds.html.
About Dolby Laboratories
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.